Logo image of CENX

CENTURY ALUMINUM COMPANY (CENX) Stock Fundamental Analysis

USA - NASDAQ:CENX - US1564311082 - Common Stock

31.32 USD
-0.28 (-0.89%)
Last: 10/9/2025, 8:59:57 PM
31.56 USD
+0.24 (+0.77%)
Pre-Market: 10/10/2025, 8:00:17 AM
Fundamental Rating

4

CENX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 156 industry peers in the Metals & Mining industry. While CENX is still in line with the averages on profitability rating, there are concerns on its financial health. CENX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CENX was profitable.
CENX had a positive operating cash flow in the past year.
In the past 5 years CENX reported 4 times negative net income.
In multiple years CENX reported negative operating cash flow during the last 5 years.
CENX Yearly Net Income VS EBIT VS OCF VS FCFCENX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.71%, CENX is in the better half of the industry, outperforming 77.56% of the companies in the same industry.
CENX has a better Return On Equity (15.35%) than 87.82% of its industry peers.
CENX's Return On Invested Capital of 9.44% is amongst the best of the industry. CENX outperforms 82.05% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CENX is significantly below the industry average of 12.16%.
The 3 year average ROIC (3.18%) for CENX is below the current ROIC(9.44%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.71%
ROE 15.35%
ROIC 9.44%
ROA(3y)4.38%
ROA(5y)-1.26%
ROE(3y)10.09%
ROE(5y)-6.4%
ROIC(3y)3.18%
ROIC(5y)N/A
CENX Yearly ROA, ROE, ROICCENX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

CENX has a Profit Margin of 4.57%. This is in the better half of the industry: CENX outperforms 71.15% of its industry peers.
CENX has a better Operating Margin (7.40%) than 62.18% of its industry peers.
CENX's Operating Margin has improved in the last couple of years.
CENX has a Gross Margin (10.07%) which is comparable to the rest of the industry.
CENX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.4%
PM (TTM) 4.57%
GM 10.07%
OM growth 3Y20%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.87%
GM growth 5YN/A
CENX Yearly Profit, Operating, Gross MarginsCENX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

More info and screens

1

2. Health

2.1 Basic Checks

CENX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CENX has more shares outstanding than it did 1 year ago.
CENX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CENX has a worse debt to assets ratio.
CENX Yearly Shares OutstandingCENX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CENX Yearly Total Debt VS Total AssetsCENX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.01 indicates that CENX is not a great score, but indicates only limited risk for bankruptcy at the moment.
CENX's Altman-Z score of 2.01 is on the low side compared to the rest of the industry. CENX is outperformed by 69.23% of its industry peers.
A Debt/Equity ratio of 0.64 indicates that CENX is somewhat dependend on debt financing.
CENX has a worse Debt to Equity ratio (0.64) than 81.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z 2.01
ROIC/WACC1.01
WACC9.3%
CENX Yearly LT Debt VS Equity VS FCFCENX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

CENX has a Current Ratio of 1.75. This is a normal value and indicates that CENX is financially healthy and should not expect problems in meeting its short term obligations.
CENX has a Current ratio of 1.75. This is in the lower half of the industry: CENX underperforms 64.10% of its industry peers.
CENX has a Quick Ratio of 1.75. This is a bad value and indicates that CENX is not financially healthy enough and could expect problems in meeting its short term obligations.
CENX has a Quick ratio of 0.61. This is amonst the worse of the industry: CENX underperforms 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 0.61
CENX Yearly Current Assets VS Current LiabilitesCENX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

CENX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 641.67%, which is quite impressive.
The Revenue has grown by 15.38% in the past year. This is quite good.
Measured over the past years, CENX shows a small growth in Revenue. The Revenue has been growing by 3.87% on average per year.
EPS 1Y (TTM)641.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2900%
Revenue 1Y (TTM)15.38%
Revenue growth 3Y0.12%
Revenue growth 5Y3.87%
Sales Q2Q%12%

3.2 Future

Based on estimates for the next years, CENX will show a very strong growth in Earnings Per Share. The EPS will grow by 62.41% on average per year.
CENX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.44% yearly.
EPS Next Y112.35%
EPS Next 2Y59.98%
EPS Next 3Y62.41%
EPS Next 5YN/A
Revenue Next Year21.11%
Revenue Next 2Y11.33%
Revenue Next 3Y10.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CENX Yearly Revenue VS EstimatesCENX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
CENX Yearly EPS VS EstimatesCENX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.60, which indicates a rather expensive current valuation of CENX.
Compared to the rest of the industry, the Price/Earnings ratio of CENX indicates a rather cheap valuation: CENX is cheaper than 85.90% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.70. CENX is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 11.13, the valuation of CENX can be described as reasonable.
CENX's Price/Forward Earnings ratio is rather cheap when compared to the industry. CENX is cheaper than 81.41% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.15. CENX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 17.6
Fwd PE 11.13
CENX Price Earnings VS Forward Price EarningsCENX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CENX indicates a somewhat cheap valuation: CENX is cheaper than 67.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.87
CENX Per share dataCENX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

CENX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CENX has a very decent profitability rating, which may justify a higher PE ratio.
CENX's earnings are expected to grow with 62.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y59.98%
EPS Next 3Y62.41%

More info and screens

0

5. Dividend

5.1 Amount

CENX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CENTURY ALUMINUM COMPANY

NASDAQ:CENX (10/9/2025, 8:59:57 PM)

Premarket: 31.56 +0.24 (+0.77%)

31.32

-0.28 (-0.89%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners61.86%
Inst Owner Change0.01%
Ins Owners0.97%
Ins Owner Change0%
Market Cap2.92B
Analysts82.5
Price Target27.54 (-12.07%)
Short Float %11.87%
Short Ratio3.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-23.64%
Min EPS beat(2)-36.41%
Max EPS beat(2)-10.87%
EPS beat(4)2
Avg EPS beat(4)21.32%
Min EPS beat(4)-36.41%
Max EPS beat(4)124.6%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.14%
Min Revenue beat(2)0.68%
Max Revenue beat(2)7.6%
Revenue beat(4)3
Avg Revenue beat(4)6.75%
Min Revenue beat(4)-1.34%
Max Revenue beat(4)20.06%
Revenue beat(8)6
Avg Revenue beat(8)5.91%
Revenue beat(12)8
Avg Revenue beat(12)4.73%
Revenue beat(16)9
Avg Revenue beat(16)2.71%
PT rev (1m)5.88%
PT rev (3m)19.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.75%
EPS NY rev (1m)29.38%
EPS NY rev (3m)-6.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)10.99%
Revenue NY rev (1m)2.12%
Revenue NY rev (3m)9.2%
Valuation
Industry RankSector Rank
PE 17.6
Fwd PE 11.13
P/S 1.2
P/FCF N/A
P/OCF 49.63
P/B 4.04
P/tB 4.04
EV/EBITDA 12.87
EPS(TTM)1.78
EY5.68%
EPS(NY)2.82
Fwd EY8.99%
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)0.63
OCFY2.01%
SpS26.06
BVpS7.76
TBVpS7.76
PEG (NY)0.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.71%
ROE 15.35%
ROCE 12.01%
ROIC 9.44%
ROICexc 9.7%
ROICexgc 9.7%
OM 7.4%
PM (TTM) 4.57%
GM 10.07%
FCFM N/A
ROA(3y)4.38%
ROA(5y)-1.26%
ROE(3y)10.09%
ROE(5y)-6.4%
ROIC(3y)3.18%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)3.31%
ROICexgc(5y)N/A
ROCE(3y)4.05%
ROCE(5y)N/A
ROICexcg growth 3Y6.18%
ROICexcg growth 5YN/A
ROICexc growth 3Y6.18%
ROICexc growth 5YN/A
OM growth 3Y20%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.87%
GM growth 5YN/A
F-Score6
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Debt/EBITDA 1.76
Cap/Depr 99.02%
Cap/Sales 3.32%
Interest Coverage 4.72
Cash Conversion 22.53%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 0.61
Altman-Z 2.01
F-Score6
WACC9.3%
ROIC/WACC1.01
Cap/Depr(3y)115.12%
Cap/Depr(5y)92.4%
Cap/Sales(3y)3.72%
Cap/Sales(5y)3.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)641.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2900%
EPS Next Y112.35%
EPS Next 2Y59.98%
EPS Next 3Y62.41%
EPS Next 5YN/A
Revenue 1Y (TTM)15.38%
Revenue growth 3Y0.12%
Revenue growth 5Y3.87%
Sales Q2Q%12%
Revenue Next Year21.11%
Revenue Next 2Y11.33%
Revenue Next 3Y10.44%
Revenue Next 5YN/A
EBIT growth 1Y1305.47%
EBIT growth 3Y20.15%
EBIT growth 5YN/A
EBIT Next Year231.45%
EBIT Next 3Y66.3%
EBIT Next 5YN/A
FCF growth 1Y81.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y232.06%
OCF growth 3YN/A
OCF growth 5YN/A